Questcor Pharmaceuticals (Nasdaq: QCOR) reported earnings on Oct. 23. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Sep. 30 (Q3), Questcor Pharmaceuticals beat expectations on revenues and crushed expectations on earnings per share.

Compared to the prior-year quarter, revenue increased significantly and GAAP earnings per share grew significantly.

Margins expanded across the board.

Revenue details
 Questcor Pharmaceuticals recorded revenue of $140.3 million. The 12 analysts polled by S&P Capital IQ expected a top line of $129.0 million on the same basis. GAAP reported sales were much higher than the prior-year quarter's $59.8 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.91. The seven earnings estimates compiled by S&P Capital IQ predicted $0.73 per share. GAAP EPS of $0.91 for Q3 were 160% higher than the prior-year quarter's $0.35 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 94.7%, 90 basis points better than the prior-year quarter. Operating margin was 60.1%, 390 basis points better than the prior-year quarter. Net margin was 39.7%, 150 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $134.4 million. On the bottom line, the average EPS estimate is $0.79.

Next year's average estimate for revenue is $471.8 million. The average EPS estimate is $2.75.

Investor sentiment
 The stock has a two-star rating (out of five) at Motley Fool CAPS, with 459 members out of 519 rating the stock outperform, and 60 members rating it underperform. Among 130 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 102 give Questcor Pharmaceuticals a green thumbs-up, and 28 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Questcor Pharmaceuticals is outperform, with an average price target of $44.89.

Can your retirement portfolio provide you with enough income to last? You'll need more than Questcor Pharmaceuticals. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.